Viewing Study NCT00044733


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-31 @ 1:21 AM
Study NCT ID: NCT00044733
Status: COMPLETED
Last Update Posted: 2006-05-18
First Post: 2002-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module